Please Login to read the full article.
Clinica
St Jude: CE mark for Genesis migraine therapy the "starting point" of new neurostim opportunity
08 September 2011
Tina Tan
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- INS 2011: Medtronic CE marks new neurostim technique to relieve pain; St Jude widens market for Epiducer
- Quarterly results round-up: St Jude and Quest cut jobs to rein in costs, Baxter strong again
- Boston aims to boost flagging CRM sales with $1.35bn buy of leadless ICD firm
- Quarterly results round-up: Boston hit by weak CRM market, Styker's profits down again
Other Informa News
EVENTS
